Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2651 |
|
| Actual shortage: | 257 (10%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 9 (0%) | |
| Resolved: | 2385 (90%) | |
Discontinuation Reports |
250 |
|
| To be discontinued: | 3 (1%) | |
| Discontinued: | 247 (99%) | |
| Reversed: | 0 (0%) | |
Late reports |
329 (11%) |
|
Overdue reports |
26 (10%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-ECTOSONE | 0.1% | LOTION | Resolved | 2020-03-26 | 2020-04-23 | 109601 |
| TEVA-ECTOSONE | 0.1% | LOTION | Resolved | 2020-09-24 | 2020-10-01 | 124953 |
| TEVA-ECTOSONE | 0.1% | LOTION | Resolved | 2021-03-25 | 2021-04-01 | 136300 |
| TEVA-ECTOSONE | 0.1% | LOTION | Resolved | 2021-07-29 | 2021-09-30 | 143242 |
| TEVA-ECTOSONE | 0.1% | LOTION | Resolved | 2021-08-27 | 2023-12-05 | 144715 |
| TEVA-ECTOSONE | 0.1% | LOTION | Resolved | 2022-09-22 | 2022-12-22 | 169957 |
| TEVA-ECTOSONE | 0.1% | CREAM | Resolved | 2022-12-22 | 2023-12-14 | 179180 |
| TEVA-ECTOSONE | 0.1% | LOTION | Resolved | 2023-04-27 | 2023-07-05 | 190689 |
| TEVA-ECTOSONE | 0.05% | CREAM | Resolved | 2023-06-08 | 2023-11-16 | 194068 |
| TEVA-ECTOSONE | 0.05% | LOTION | Resolved | 2023-06-08 | 2024-03-07 | 194074 |
| TEVA-ECTOSONE | 0.05% | LOTION | Resolved | 2023-06-16 | 2023-07-05 | 195189 |
| TEVA-ECTOSONE | 0.05% | CREAM | Resolved | 2023-06-19 | 2023-07-05 | 195600 |
| TEVA-ECTOSONE | 0.1% | LOTION | Resolved | 2023-06-19 | 2024-03-18 | 195634 |
| TEVA-ECTOSONE | 0.1% | CREAM | Resolved | 2023-06-20 | 2023-07-05 | 195795 |
| TEVA-ECTOSONE | 0.05% | LOTION | Actual shortage | 2024-03-28 | 2024-03-28 | 223832 |
| TEVA-EFAVIRENZ | 600MG | TABLET | Resolved | 2020-05-01 | 2020-06-11 | 113782 |
| TEVA-EFAVIRENZ | 600MG | TABLET | Resolved | 2023-04-27 | 2023-07-06 | 190767 |
| TEVA-EFAVIRENZ | 600MG | TABLET | Resolved | 2023-06-20 | 2023-07-06 | 195858 |
| TEVA-EFAVIRENZ/EMTRICITABINE/TENOFOVIR | 600MG 200MG 300MG | TABLET | Resolved | 2020-04-16 | 2020-05-08 | 112370 |
| TEVA-EFAVIRENZ/EMTRICITABINE/TENOFOVIR | 300MG 200MG 600MG | TABLET | Resolved | 2022-06-03 | 2023-02-11 | 161940 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-NYSTATIN | 100000UNIT | CREAM | Discontinued | 2020-07-10 | 2020-07-10 | 120056 |
| TEVA-PANTOPRAZOLE MAGNESIUM | 40MG | TABLET (DELAYED-RELEASE) | Discontinued | 2021-02-12 | 2021-02-12 | 133891 |
| TEVA-PAROXETINE | 10MG | TABLET | Discontinued | 2019-04-11 | 2019-04-11 | 81313 |
| TEVA-PAROXETINE | 30MG | TABLET | Discontinued | 2019-12-09 | 2019-12-09 | 100540 |
| TEVA-PAROXETINE | 20MG | TABLET | Discontinued | 2019-12-09 | 2019-12-09 | 100547 |
| TEVA-PAROXETINE | 10MG | TABLET | Discontinued | 2020-02-21 | 2020-02-21 | 106898 |
| TEVA-PAROXETINE | 30MG | TABLET | Discontinued | 2020-02-21 | 2020-02-21 | 106901 |
| TEVA-PIOGLITAZONE | 15MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 65026 |
| TEVA-PIOGLITAZONE | 30MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 65030 |
| TEVA-PIOGLITAZONE | 45MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 65033 |
| TEVA-PRAMIPEXOLE | 1.5MG | TABLET | Discontinued | 2017-06-27 | 2017-06-27 | 14007 |
| TEVA-PREDNISONE | 5MG | TABLET | Discontinued | 2019-04-11 | 2019-04-11 | 81376 |
| TEVA-PREGABALIN | 75MG | CAPSULE | Discontinued | 2020-07-10 | 2020-07-10 | 120033 |
| TEVA-QUETIAPINE | 100MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64846 |
| TEVA-QUETIAPINE | 25MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64849 |
| TEVA-QUETIAPINE | 100MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 65036 |
| TEVA-QUETIAPINE | 200MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 65039 |
| TEVA-QUETIAPINE | 25MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 65044 |
| TEVA-QUETIAPINE | 300MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 65047 |
| TEVA-QUININE | 300MG | CAPSULE | Discontinued | 2020-01-24 | 2020-01-24 | 104294 |